Tikosyn and Remicade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tikosyn (dofetilide) and Remicade (infliximab). Common drug interactions include oropharyngeal pain among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Tikosyn and Remicade. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Tikosyn?

Tikosyn has active ingredients of dofetilide. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 12,202 Tikosyn users. Check the latest studies of Tikosyn.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

13 people who take Tikosyn and Remicade together, and have interactions are studied.

What are the common drug interactions of Tikosyn and Remicade, by gender? *:

female:

Oropharyngeal pain
Diarrhoea
Colitis (inflammation of colon)
Drug ineffective
Injection site erythema (redness at injection site)
Injection site swelling
Malaise (a feeling of general discomfort or uneasiness)
Fatigue (feeling of tiredness)
Heart rate increased
Somnolence (a state of near-sleep, a strong desire for sleep)

male:

Cellulitis (infection under the skin)
Gastric ulcer haemorrhage (bleeding ulcer of stomach)

What are the common drug interactions of Tikosyn and Remicade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Protein total decreased
Cellulitis (infection under the skin)
Colitis (inflammation of colon)
Fatigue (feeling of tiredness)
Heart rate increased
Somnolence (a state of near-sleep, a strong desire for sleep)
Weight increased

60+:

Fungal infection
Blood sodium decreased
Nasal discomfort
Oropharyngeal pain
Diarrhoea
Gastric ulcer haemorrhage (bleeding ulcer of stomach)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 76.92%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 46.15%
Joint Pain: 4 people, 30.77%
Hypersensitivity: 4 people, 30.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%
High Blood Pressure: 3 people, 23.08%
Asthma: 3 people, 23.08%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 15.38%
Sinusitis (inflammation of sinus): 2 people, 15.38%
Arrhythmias (irregular heartbeat): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Tikosyn and Remicade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously